The Pharmacokinetic and Pharmacodynamic Drug-drug Interaction Potential of Cannabidiol. (PubMed, Drug Metab Bioanal) - Oct 8, 2026 - "There were a total of 19 major interactions (colchicine, levomethadyl acetate, Mipomersen, propoxyphene, brexanolone, buprenorphine, esketamine, fezolinetant, ketamine, leflunomide, levoketoconazole, lomitapide, morphine, pexidartinib, pralsetinib, relugolix, sodium oxybate, teriflunomide, venetoclax), 393 moderate interactions, 49 minor interactions, and 828 of unknown significance. The available information allows us to identify drugs with potential Drug-Drug Interactions of varying severity. This information can be used to improve treatment safety."
Journal • PK/PD data • Review • CNS Disorders
|
|
Guillermo Alberto Keller; Jorge Alejandro Aimar
|